Treatment of cervicogenic headache with application of multicomponent bioregulation drug
Introduction. According to the data of various authors Cervicogenic headache (CH) is met in 2.5 to 70% of population. Diagnostic criteria are described at The International classification of headache (3d revision). CH represents a heterogeneous group of headaches based on functional and organic chan...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Russo |
| Cyhoeddwyd: |
Remedium Group LLC
2020-07-01
|
| Cyfres: | Медицинский совет |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.med-sovet.pro/jour/article/view/5686 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
